XXII: This is a reiteration from Monday's watchlist as I believe there is still upside to $2.90.
85.5M float. Following a nice upward channel since March 2017. Either a U-Shape or potential cup and handle formation taking shape. With the RSI closing in to 70 and a MACD cross on Friday, this look like it could be close to a major move.
News: On August 25, 2017, that the US Food and Drug Administration (FDA) has approved KEDRAB™, a human rabies immune globulin (HRIG), for the post-exposure prevention of rabies infection, when administered after contact with a rabid or possibly rabid animal. Stock price is up 25% since then and with the technical indicators lining up, we could see another nice push up.
CG: Technicals - A very similar up trending channel to XXII. Note the volume was more than double the EMS(50) volume. Good confirmation on the daily uptick. MACD should cross on Tuesday leading to more momentum. Looking for a potential PT of 23.00 on the swing.
News - Three analyst upgrades since May 2017. No other recent new except for a $400 million offering of 16,000,000 of its 5.875% Series A Preferred Units representing limited partner interests with a liquidation preference of $25.00 per unit. The offering is expected to close on September 13, 2017, subject to satisfaction of customary closing conditions.
CERC: Technical - Float of 24.9M. Very strong momentum on Monday easily took the price about the resistance line. Although volume was just below the EMA(50) on Monday,i'm looking for increased momentum and volume and a PT of 1.00 within the next 2 days. Potentially on Tuesday as technical indicators are close to a major move up.
NEWS: On August 14, 2017, CERC announced it has sold all the rights to CERC-501 to Janssen Pharmaceuticals, Inc. for $25 million, with $21.25 million paid in cash upon closing of the deal and $3.75 million placed into a 12-month escrow account. Thus permitting it to operate till the end of 2018. Shareholders liked the news as the price has increased nicely since then.
DEPO: Technicals -After consolidating for over a month, DEPO finally broke out on Monday. Volume has been steadily going up for the past few days. Looking for an initial PT of 7.47, then 9.07 if momentum continues. MA(9) about to cross MA(20). Float of 62.2M.
Securities class action lawsuit being launched against DEPO. Psychologically and technically, this seems to push the stock price higher.
SFUN: Technicals - After 9 months of consolidation, there was strong momentum on Monday as price easily past the triple to resistance line. Next resistance is at 4.38. However, note that volume was very low on Monday. So wait for some volume confirmation before entry.
NEWS - ER was on August 29th and price has increased since then.